Bladder Cancer detection by urinary methylation markers GHSR/MAL: a validation study
Validation of the GHSR/MAL methylation marker panel on at home collected urine samples confirms its robust performance for bladder cancer detection in a hematuria population, and underscores the diagnostic potential for future clinical application.
Authors
- Judith Bosschieter (ORCID: https://orcid.org/0000-0002-0718-897X)
- Irene Beijert (ORCID: https://orcid.org/0000-0002-0510-2300)
- Anouk E. Hentschel (ORCID: https://orcid.org/0000-0001-6397-0301)
- R. Jeroen A. van Moorselaar (ORCID: https://orcid.org/0000-0002-2559-9254)
- Birgit I. Lissenberg‐Witte (ORCID: https://orcid.org/0000-0001-9448-1826)
- Paul C. Kauer
- Renske D.M. Steenbergen (ORCID: https://orcid.org/0000-0002-2327-9839)
- Jakko A. Nieuwenhuijzen (ORCID: https://orcid.org/0000-0002-8977-5501)
- Yara van den Burgt
Institutions
- Dutch Cancer Society (NL)
- OLVG (NL)
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- Cancer Center Amsterdam (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- World Journal of Urology
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1007/s00345-024-05287-5
- Citations
- 9
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.15